---
authors:
- Ebell, Mark H
category: Clinical Trial
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/38804768/
file_path: 2024/05/pci-is-better-than-placebo-for-stable-angina-in-patients-who.md
issue: '5'
keywords:
- Humans
- Percutaneous Coronary Intervention
- Randomized Controlled Trials as Topic
- Treatment Outcome
- Angina, Stable
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Angina, Stable
- Percutaneous Coronary Intervention
- Treatment Outcome
- Randomized Controlled Trials as Topic
original_format: PubMed
pages: '477'
patient_population: Adults
peer_reviewed: true
pmid: '38804768'
processed_date: '2025-07-30'
publication_date: '2024-05-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-10'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: PCI Is Better Than Placebo for Stable Angina in Patients Who Do Not Take Antianginal
  Medications.
topics:
- Family Medicine
volume: '109'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '38804768'
  title: PCI Is Better Than Placebo for Stable Angina in Patients Who Do Not Take
    Antianginal Medications.
  authors:
  - last_name: Ebell
    fore_name: Mark H
    initials: MH
    affiliation: Professor, University of Georgia, Athens, Ga.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '109'
    issue: '5'
  publication_info:
    year: '2024'
    month: '05'
    full_date: '2024-05-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Angina, Stable
    major_topic: true
    qualifiers:
    - qualifier: drug therapy
      major_topic: false
  - descriptor: Percutaneous Coronary Intervention
    major_topic: true
    qualifiers:
    - qualifier: methods
      major_topic: false
  - descriptor: Treatment Outcome
    major_topic: false
  - descriptor: Randomized Controlled Trials as Topic
    major_topic: false
  publication_types: *id001
related_articles:
- pmid: '38804768'
  title: PCI Is Better Than Placebo for Stable Angina in Patients Who Do Not Take
    Antianginal Medications.
  authors:
  - name: Ebell MH
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2024 May
- pmid: '38015442'
  title: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable
    Angina.
  authors:
  - name: Rajkumar CA
    authtype: Author
    clusterid: ''
  - name: Foley MJ
    authtype: Author
    clusterid: ''
  - name: Ahmed-Jushuf F
    authtype: Author
    clusterid: ''
  - name: Nowbar AN
    authtype: Author
    clusterid: ''
  - name: Simader FA
    authtype: Author
    clusterid: ''
  - name: Davies JR
    authtype: Author
    clusterid: ''
  - name: O'Kane PD
    authtype: Author
    clusterid: ''
  - name: Haworth P
    authtype: Author
    clusterid: ''
  - name: Routledge H
    authtype: Author
    clusterid: ''
  - name: Kotecha T
    authtype: Author
    clusterid: ''
  - name: Gamma R
    authtype: Author
    clusterid: ''
  - name: Clesham G
    authtype: Author
    clusterid: ''
  - name: Williams R
    authtype: Author
    clusterid: ''
  - name: Din J
    authtype: Author
    clusterid: ''
  - name: Nijjer SS
    authtype: Author
    clusterid: ''
  - name: Curzen N
    authtype: Author
    clusterid: ''
  - name: Ruparelia N
    authtype: Author
    clusterid: ''
  - name: Sinha M
    authtype: Author
    clusterid: ''
  - name: Dungu JN
    authtype: Author
    clusterid: ''
  - name: Ganesananthan S
    authtype: Author
    clusterid: ''
  - name: Khamis R
    authtype: Author
    clusterid: ''
  - name: Mughal L
    authtype: Author
    clusterid: ''
  - name: Kinnaird T
    authtype: Author
    clusterid: ''
  - name: Petraco R
    authtype: Author
    clusterid: ''
  - name: Spratt JC
    authtype: Author
    clusterid: ''
  - name: Sen S
    authtype: Author
    clusterid: ''
  - name: Sehmi J
    authtype: Author
    clusterid: ''
  - name: Collier DJ
    authtype: Author
    clusterid: ''
  - name: Sohaib A
    authtype: Author
    clusterid: ''
  - name: Keeble TR
    authtype: Author
    clusterid: ''
  - name: Cole GD
    authtype: Author
    clusterid: ''
  - name: Howard JP
    authtype: Author
    clusterid: ''
  - name: Francis DP
    authtype: Author
    clusterid: ''
  - name: Shun-Shin MJ
    authtype: Author
    clusterid: ''
  - name: Al-Lamee RK
    authtype: Author
    clusterid: ''
  - name: ORBITA-2 Investigators
    authtype: CollectiveName
    clusterid: ''
  source: N Engl J Med
  pubdate: 2023 Dec 21
- pmid: '35156616'
  title: 'A double-blind randomised placebo-controlled trial of percutaneous coronary
    intervention for the relief of stable angina without antianginal medications:
    design and rationale of the ORBITA-2 trial.'
  authors:
  - name: Nowbar AN
    authtype: Author
    clusterid: ''
  - name: Rajkumar C
    authtype: Author
    clusterid: ''
  - name: Foley M
    authtype: Author
    clusterid: ''
  - name: Ahmed-Jushuf F
    authtype: Author
    clusterid: ''
  - name: Howard JP
    authtype: Author
    clusterid: ''
  - name: Seligman H
    authtype: Author
    clusterid: ''
  - name: Petraco R
    authtype: Author
    clusterid: ''
  - name: Sen S
    authtype: Author
    clusterid: ''
  - name: Nijjer SS
    authtype: Author
    clusterid: ''
  - name: Shun-Shin MJ
    authtype: Author
    clusterid: ''
  - name: Keeble TR
    authtype: Author
    clusterid: ''
  - name: Sohaib A
    authtype: Author
    clusterid: ''
  - name: Collier D
    authtype: Author
    clusterid: ''
  - name: McVeigh P
    authtype: Author
    clusterid: ''
  - name: Harrell FE
    authtype: Author
    clusterid: ''
  - name: Francis DP
    authtype: Author
    clusterid: ''
  - name: Al-Lamee RK
    authtype: Author
    clusterid: ''
  source: EuroIntervention
  pubdate: 2022 Apr 22
- pmid: '32877651'
  title: 'Efficacy and safety of trimetazidine after percutaneous coronary intervention
    (ATPCI): a randomised, double-blind, placebo-controlled trial.'
  authors:
  - name: Ferrari R
    authtype: Author
    clusterid: ''
  - name: Ford I
    authtype: Author
    clusterid: ''
  - name: Fox K
    authtype: Author
    clusterid: ''
  - name: Challeton JP
    authtype: Author
    clusterid: ''
  - name: Correges A
    authtype: Author
    clusterid: ''
  - name: Tendera M
    authtype: Author
    clusterid: ''
  - name: Widimsk√Ω P
    authtype: Author
    clusterid: ''
  - name: Danchin N
    authtype: Author
    clusterid: ''
  - name: ATPCI investigators
    authtype: CollectiveName
    clusterid: ''
  source: Lancet
  pubdate: 2020 Sep 19
- pmid: '23922143'
  title: Antianginal therapy before percutaneous coronary intervention.
  authors:
  - name: Borden WB
    authtype: Author
    clusterid: ''
  - name: Spertus JA
    authtype: Author
    clusterid: ''
  - name: Mushlin AI
    authtype: Author
    clusterid: ''
  - name: Roe MT
    authtype: Author
    clusterid: ''
  - name: McCoy LA
    authtype: Author
    clusterid: ''
  - name: Redberg RF
    authtype: Author
    clusterid: ''
  source: Circ Cardiovasc Interv
  pubdate: 2013 Aug
---

# PCI Is Better Than Placebo for Stable Angina in Patients Who Do Not Take Antianginal Medications.

**Authors:** Ebell, Mark H

**Published in:** American family physician | Vol. 109, No. 5 | 2024-05-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/38804768/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Angina, Stable, Percutaneous Coronary Intervention, Treatment Outcome, Randomized Controlled Trials as Topic

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/38804768/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
